Posted April 17, 2009
Drug startup BioMarck lands $6.3M in new financing
Post a comment
Print this storyE-mail story
Share
Research Triangle Park, N.C. —
Triangle-based firm, which licsened its technology from NCSU, will use funds for clinical trial of its inhalation treatment for lung disease. Copyright 2013 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
